SCHEMBL9534693

SCHEMBL9534693

[CH](c1cccnc1)C1CCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B2 P19099 6/20 0.47
ALDH1A1 P00352 4/20 0.47
CYP11B1 P15538 3/20 0.47
NPSR1 Q6W5P4 1/20 0.46
MAPT P10636 5/20 0.45
RAB9A P51151 4/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
HTT P42858 2/20 0.45
ATM Q13315 2/20 0.45
CHRNB2 P17787 2/20 0.44
CHRNB4 P30926 2/20 0.44
CHRNA3 P32297 2/20 0.44
CHRNA4 P43681 2/20 0.44
CYP19A1 P11511 4/20 0.42
NPC1 O15118 3/20 0.42
MAPK1 P28482 3/20 0.42
KDM4E B2RXH2 1/20 0.42
JUN P05412 1/20 0.42
NFKB1 P19838 1/20 0.42
GPR55 Q9Y2T6 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8911537 0.94 ALDH1A1 (0.51) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL8482013 0.84 CHRNB2 (0.43) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL18700858 0.77 CYP11B2 (0.52) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL18700856 0.77 CYP11B2 (0.52) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL1119433 0.74 ALDH1A1 (0.42) ALDH1A1NPSR1MAPTSMN1; SMN2KDM4E
SCHEMBL5133115 0.74 CHRNB2 (0.53) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL27802133 0.73 CYP11B1 (0.57) CYP11B2ALDH1A1CYP11B1MAPTRAB9A
SCHEMBL25030388 0.73 ALDH1A1 (0.56) CYP11B2ALDH1A1CYP11B1NPSR1MAPT
SCHEMBL25238428 0.70 CYP11B2 (0.53) CYP11B2ALDH1A1CYP11B1MAPTRAB9A
Nicotinaldehyde SCHEMBL11385746 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0532693-A1 1,4-DIAMINO-2,3-DIHYDROXYBUTANES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1993-03-24 EP disclosed